FDA Food recall F-0647-2021
Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9
- FDA Food
- Class II
- ongoing
- Published 2021-06-09
On 2021-06-09 the FDA classified a Class II recall of Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9 by Hi Tech Pharmaceuticals, citing the firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-0647-2021 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2021-05-12 |
| Published | 2021-06-09 |
| Last updated | 2026-09-13 11:50 UTC |
| Company | Hi Tech Pharmaceuticals |
| Distribution | AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, VT, WA, WI |
Product
Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9
Reason
The firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).
Identifiers
| upc | 857084000569 |
|---|---|
| code_info | Lot # 001211197, Exp. 12/25 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:50 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0647-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.